Dysregulation of Metabolism and Proteostasis in Skeletal Muscle of a Presymptomatic Pompe Mouse Model
Cells · 2023
DOI: 10.3390/cells12121602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Marlena Rohm und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr-University Bochum, 44789 Bochum, Germany. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Society for Muscle Diseases DGM, FoRUM program of the Ruhr-University Bochum, Heimer Foundation, Bielefeld.
Abstract (Originalsprache)
Pompe disease is a rare genetic metabolic disorder caused by mutations in acid-alpha glucoside (GAA) leading to pathological lysosomal glycogen accumulation associated with skeletal muscle weakness, respiratory difficulties and cardiomyopathy, dependent from the GAA residual enzyme activity. This study aimed to investigate early proteomic changes in a mouse model of Pompe disease and identify potential therapeutic pathways using proteomic analysis of skeletal muscles from pre-symptomatic Pompe mice. For this purpose, quadriceps samples of Gaa6neo/6neo mutant (Pompe) and wildtype mice, at the age of six weeks, were studied with three biological replicates for each group. The data were validated with skeletal muscle morphology, immunofluorescence studies and western blot analysis. Proteomic profiling identified 538 significantly upregulated and 16 significantly downregulated proteins in quadriceps muscles derived from Pompe animals compared to wildtype mice. The majority of significantly upregulated proteins were involved in metabolism, translation, folding, degrading and vesicular transport, with some having crucial roles in the etiopathology of other neurological or neuromuscular diseases. This study highlights the importance of the early diagnosis and treatment of Pompe disease and suggests potential add-on therapeutic strategies targeting protein dysregulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr-University Bochum, 44789 Bochum, Germany.
- Heimer Institute for Muscle Research, BG-University Hospital Bergmannsheil gGmbH, Ruhr-University Bochum, 44789 Bochum, Germany.
- Department of Neuropediatrics, University Hospital Essen, Duisburg-Essen University, 45147 Essen, Germany.
- Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
- Institute of Neuropathology, Justus Liebig University, 35390 Giessen, Germany.
- Leibniz-Institut für Analytische Wissenschaften, 44139 Dortmund, Germany.
ORCID-Profile: Marlena Rohm, Leon Volke, Lara Schlaffke, Andreas Roos, Andreas Hentschel, Matthias Vorgerd
Förderung
- German Society for Muscle Diseases DGM
- FoRUM program of the Ruhr-University Bochum
- Heimer Foundation, Bielefeld
Zitieren
APA
Rohm, M., Volke, L., Schlaffke, L., Rehmann, R., Südkamp, N., Roos, A., Schänzer, A., Hentschel, A., & Vorgerd, M. (2023). Dysregulation of Metabolism and Proteostasis in Skeletal Muscle of a Presymptomatic Pompe Mouse Model. Cells. https://doi.org/10.3390/cells12121602
Vancouver
Rohm M, Volke L, Schlaffke L, Rehmann R, Südkamp N, Roos A, et al. Dysregulation of Metabolism and Proteostasis in Skeletal Muscle of a Presymptomatic Pompe Mouse Model. Cells. 2023. doi:10.3390/cells12121602
BibTeX
@article{Rohm2023,
author = {Rohm, Marlena and Volke, Leon and Schlaffke, Lara and Rehmann, Robert and Südkamp, Nicolina and Roos, Andreas and Schänzer, Anne and Hentschel, Andreas and Vorgerd, Matthias},
title = {Dysregulation of Metabolism and Proteostasis in Skeletal Muscle of a Presymptomatic Pompe Mouse Model},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12121602}
}
EUVIMED